脑脊液β-淀粉样蛋白1-42两种免疫测定方法的比较评价
该研究在49份脑脊液样本中比较ELISA与CLEIA(Lumipulse G600II平台)测定βA42的一致性。Passing-Bablok回归显示比例系统差异,Pearson r为0.826,Bland-Altman分析显示ELISA测值平均比CLEIA低27.06%(95%CI -31.89至-22.23%)。作者认为两方法存在差异,实验室报告中的βA42正常水平cut-off应重新评估。
要点
- ELISA与CLEIA测定脑脊液βA42存在比例系统差异,不可直接互换。
- ELISA测值平均比CLEIA低27.06%(95%CI -31.89至-22.23%)。
- 实验室应重新评估基于原方法的βA42正常cut-off。
核心结论
- ELISA与CLEIA两种方法测定脑脊液βA42存在显著差异,实验室报告中的正常水平cut-off应重新评估。
研究设计与样本
- 在49份脑脊液样本中,分别用ELISA(Innotest β-amyloid 1-42)和CLEIA(Lumipulse G β-amyloid 1-42,Lumipulse G600II全自动平台)测定βA42。
- 采用基于固有组合不精密度(ICI)的可接受区间、Passing-Bablok回归、Pearson相关系数和Bland-Altman图比较两方法测值。
主要发现
- ICI分析显示两方法存在实质性差异。
- Passing-Bablok回归方程为y = -103.04 + 1.52×,提示存在比例系统差异,线性偏离不显著(p = .42)。
- Pearson相关系数为0.826。
- Bland-Altman图分析显示两方法存在显著系统差异:ELISA测值平均比CLEIA低27.06%(95% CI -31.89至-22.23%)。
关键数值与推荐
- Passing-Bablok回归方程:y = -103.04 + 1.52×,线性偏离p = .42。
- Pearson相关系数r = 0.826。
- ELISA测值平均比CLEIA低27.06%(95% CI -31.89至-22.23%)。
临床怎么用
- 检验科在将βA42测定方法从ELISA转换为CLEIA时,需注意两方法测值不可直接比较。
- 实验室应依据所用方法重新评估脑脊液βA42正常水平cut-off并更新报告。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
AIM OF THE STUDY: Beta-Amyloid 1-42 peptide (βA42) is a cerebro-spinal fluid (CSF) biomarker, key element of the NIA Alzheimer's disease diagnostic criteria. The enzyme-linked immunosorbent assay (ELISA) has been the mainstay method for βA42 measurement on cerebrospinal fluid (CSF). Recently, a new βA42 measurement method in chemiluminescence enzyme immunoassay (CLEIA) is available on Lumipulse G 600 II automatic platform. The aim of the work was to evaluate the concordance of the ELISA and the new method (CLEIA) in the CSF βA42 levels measurement. MATERIALS AND METHODS: CSF βA42 levels were assayed in 49 samples using the ELISA method (Innotest β- amyloid 1-42, Fujirebio Europe N.V., Gent, Belgium) and CLEIA method on Lumipulse G600II fully automatic platform (Lumipulse G β- amyloid 1-42, Fujirebio Europe N.V., Gent, Belgium). We compared values of the two methods using acceptability interval based on Inherent Combined Imprecision (ICI), the Passing-Bablok regression analysis, the Pearson correlation coefficient (r) and the Bland-Altman plot. RESULTS: The analysis of the ICI showed that the two methods differ substantially. The regression equation (y = -103.04 + 1.52×) highlighted the presence of proportional systematic difference, without significant deviation from linearity (p = .42). The Pearson correlation coefficient was 0.826. The Bland-Altman plot analysis showed a significant systematic difference in the two methods: ELISA measurements were in average -27.06% (95% CI -31.89 to -22.23%) lower compared to CLEIA ones. CONCLUSIONS: Our study highlighted a difference between the two methods. Therefore, the cut-off for the normal levels of βA42 should be reviewed in the laboratory report.
引用
- Zecca C, Brescia V, Piccininni M, et al. Comparative evaluation of two immunoassays for cerebrospinal fluid β-Amyloid1-42 measurement. Clin Chim Acta. 2019. PMID: 30844363. doi:10.1016/j.cca.2019.02.033
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。